Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Aging Cell. 2011 Apr 7;10(3):506–519. doi: 10.1111/j.1474-9726.2011.00688.x

Figure 2. Celecoxib extends adult lifespan in a daf-16-dependent manner.

Figure 2

Survival curves of N2 animals and (A) eat-2(ad1116), (B) cyc-1(RNAi), (C) daf-16(mu86), or (D) daf-2(e1370) mutants grown on plates containing DMSO control (blue or green) or 2 µM of celecoxib (red or orange). All drug treatments were initiated from the first day of adulthood and continued until death, except cyc-1(RNAi). In all cases, these data represent the results of a single trial. Repetition of this experiment and statistical details are summarized in Table S1.